Aim: To investigate the protective effects of ginsenoside Rb 3 , a triterpenoid saponin isolated from the leaves of Panax notoginseng, on ischemic and reperfusion injury model of PC12 cells and elucidate the related mechanisms. Methods: PC12 cells exposed to oxygen and glucose deprivation (OGD) and restoration (OGD-Rep) were used as an in vitro model of ischemia and reperfusion. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and lactate dehydrogenase (LDH) leakage were used to evaluate the protective effects of ginsenoside Rb 3 . Cellular apoptosis and mitochondrial membrane potential (MMP) were analyzed using flow cytometry. Intracellular calcium ion concentration ([Ca 2+ ] i ) was detected using fluorophotometer system. Caspase-3, -8, and -9 activities were measured using assay kits with an ELISA reader. Western blotting assay was used to evaluate the release of cytochrome c and expression of caspase-3, Bcl-2 and Bax proteins. Results: It was shown that ginsenoside Rb 3 (0.1-10 μmol/L) significantly increased cell viability and inhibited LDH release in a dosedependent manner on the ischemic model. In addition, ginsenoside Rb 3 also significantly inhibited ischemic injury-induced apoptosis, [Ca 2+ ] i elevation, and decrease of MMP. Meanwhile, pretreatment with ginsenoside Rb 3 significantly induced an increase of Bcl-2 protein expression and a decrease of cytosolic cytochrome c, cleaved-caspase 3 and Bax protein expression, the caspase-3, -8, and -9 activity were also inhibited.
Conclusion:The results indicated that ginsenoside Rb 3 could markedly protected OGD-Rep induced ischemic injury and the mechanisms maybe related to its suppression of the intracellular Ca 2+ elevation and inhibition of apoptosis and caspase activity. Ginsenoside Rb 3 could be a promising candidate in the development of a novel class of anti-ischemic agent.